Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up

SH Nahm; A Rembielak; H Peach; PC Lorigan; Contributing Clinicians

doi:10.1016/j.clon.2020.06.017

Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up

SH Nahm, A Rembielak, H Peach, PC Lorigan, Contributing Clinicians

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	e54-e57
Number of pages	4
Journal	Clinical Oncology
Volume	33
Issue number	1
DOIs	https://doi.org/10.1016/j.clon.2020.06.017
Publication status	Published - 1 Jan 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clon.2020.06.017

Cite this

@article{a6f5f0d6f580498f909463367923a651,

title = "Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up",

author = "SH Nahm and A Rembielak and H Peach and PC Lorigan and Contributing Clinicians",

note = "Funding Information: P.C. Lorigan reports personal fees and other from BMS, personal fees from Merck, personal fees and other from Novartis, personal fees and other from GSK, personal fees and other from Amgen, personal fees and other from Chugai, outside the submitted work.",

year = "2021",

month = jan,

day = "1",

doi = "10.1016/j.clon.2020.06.017",

language = "English",

volume = "33",

pages = "e54--e57",

journal = "Clinical Oncology",

issn = "0936-6555",

publisher = "W.B. Saunders Co. Ltd",

number = "1",

}

TY - JOUR

T1 - Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic

T2 - Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up

AU - Nahm, SH

AU - Rembielak, A

AU - Peach, H

AU - Lorigan, PC

AU - Clinicians, Contributing

N1 - Funding Information: P.C. Lorigan reports personal fees and other from BMS, personal fees from Merck, personal fees and other from Novartis, personal fees and other from GSK, personal fees and other from Amgen, personal fees and other from Chugai, outside the submitted work.

PY - 2021/1/1

Y1 - 2021/1/1

UR - http://europepmc.org/abstract/med/32631767

UR - http://www.scopus.com/inward/record.url?scp=85087406633&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/144e2420-78a7-3003-9b45-fc0e8c337660/

U2 - 10.1016/j.clon.2020.06.017

DO - 10.1016/j.clon.2020.06.017

M3 - Editorial

C2 - 32631767

SN - 0936-6555

VL - 33

SP - e54-e57

JO - Clinical Oncology

JF - Clinical Oncology

IS - 1

ER -

Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up

UN SDGs

Access to Document

Other files and links

Cite this